Christine Murray - Dec 29, 2022 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
Director
Signature
/s/ Sriram Ryali, Attorney-in-Fact
Stock symbol
EIGR
Transactions as of
Dec 29, 2022
Transactions value $
-$6,104
Form type
4
Date filed
1/3/2023, 07:30 PM
Previous filing
Mar 11, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIGR Common Stock Sale -$6.1K -5K -31.25% $1.22 11K Dec 29, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.